Summary: Levels of alpha-synuclein in the brainmeasured through imaging toolscould be a biomarker that would help researchers diagnose the disease better and test potential therapies faster.
Summary: Levels of alpha-synuclein in the brainmeasured through imaging toolscould be a biomarker that would help researchers diagnose the disease better and test potential therapies faster.